These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27014972)

  • 21. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
    Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P
    Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
    Qi YJ; Ward DG; Pang C; Wang QM; Wei W; Ma J; Zhang J; Lou Q; Shimwell NJ; Martin A; Wong N; Chao WX; Wang M; Ma YF; Johnson PJ
    Proteomics; 2014 Feb; 14(2-3):186-95. PubMed ID: 24259486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.
    Yang L; Rong W; Xiao T; Zhang Y; Xu B; Liu Y; Wang L; Wu F; Qi J; Zhao X; Wang H; Han N; Guo S; Wu J; Gao Y; Cheng S
    Sci China Life Sci; 2013 Jul; 56(7):638-46. PubMed ID: 23749381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
    Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
    J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation.
    Qazi AS; Sun M; Huang Y; Wei Y; Tang J
    Biomed Pharmacother; 2011 Sep; 65(6):407-16. PubMed ID: 21741201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increased coronin-1C expression is related to hepatocellular carcinoma invasion and metastasis].
    Wu L; Hou JX; Peng CW; Zhang YH; Chen C; Chen LD; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):516-9. PubMed ID: 20678442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
    Hu H; Gao L; Wang C; Li Y; Ma H; Chen L; Qin J; Liu B; Liu Y; Liang C
    Discov Med; 2015 May; 19(106):333-41. PubMed ID: 26105696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.
    Jiang K; Li W; Shang S; Sun L; Guo K; Zhang S; Liu Y
    Oncol Rep; 2016 Apr; 35(4):2141-50. PubMed ID: 26820712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential analysis of tyrosine-phosphorylated proteins in human hepatocellular carcinoma cell lines with different metastasis potentials].
    Zhang LJ; Cui JF; Liu YK; Zhu YS; Song HY; Shen HL; Feng JT; Dai Z; Chen J; Sun RX
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):436-9. PubMed ID: 15975278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Classification and identification of the secretome of hepatocellular carcinoma cells by isoelectric focusing electrophoresis pre-fractionation strategy].
    Li X; Zhao X; Ying W; Qian X
    Se Pu; 2013 Sep; 31(9):831-7. PubMed ID: 24392619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between CD44 expression or glycosylation and hepatocellular carcinoma metastasis].
    Chen BL; Guo K; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):898-903. PubMed ID: 22525501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes.
    Shen H; Zhong F; Zhang Y; Yu H; Liu Y; Qin L; He F; Tang Z; Yang P
    Proteomics; 2015 Jun; 15(11):1793-800. PubMed ID: 25652264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS; Su IJ; Leu YW; Young KC; Sun HS
    Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.
    Slany A; Haudek-Prinz V; Zwickl H; Stättner S; Grasl-Kraupp B; Gerner C
    Electrophoresis; 2013 Dec; 34(24):3315-25. PubMed ID: 24115093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma.
    Valletta D; Czech B; Spruss T; Ikenberg K; Wild P; Hartmann A; Weiss TS; Oefner PJ; Müller M; Bosserhoff AK; Hellerbrand C
    Carcinogenesis; 2014 Jun; 35(6):1407-15. PubMed ID: 24590895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro.
    Hago AM; Gamallat Y; Mahmoud SA; Huang Y; Zhang J; Mahmoud YK; Wang J; Wei Y; Wang L; Zhou S; Awsh MA; Yabasin IB; Tang J
    Biomed Pharmacother; 2017 Jan; 85():209-217. PubMed ID: 27914826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.